FDA Schedules Biologics Specification Workshop
This article was originally published in The Pink Sheet Daily
Executive Summary
The workshop is part of a series of activities designed to recommend a comprehensive specification process from scratch rather than amend current practices. FDA has said release of a follow-on biologics guidance is on hold until after a forum on the subject is held.